TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

W Jurczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.